270 related articles for article (PubMed ID: 15492230)
41. Peltophorum dubium and soybean Kunitz-type trypsin inhibitors induce human Jurkat cell apoptosis.
Troncoso MF; Biron VA; Longhi SA; Retegui LA; Wolfenstein-Todel C
Int Immunopharmacol; 2007 May; 7(5):625-36. PubMed ID: 17386410
[TBL] [Abstract][Full Text] [Related]
42. Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance.
Chen N; Gong J; Chen X; Meng W; Huang Y; Zhao F; Wang L; Zhou Q
Hum Pathol; 2009 Jul; 40(7):950-6. PubMed ID: 19269012
[TBL] [Abstract][Full Text] [Related]
43. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
44. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
45. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha.
Stanic I; Facchini A; Borzì RM; Vitellozzi R; Stefanelli C; Goldring MB; Guarnieri C; Facchini A; Flamigni F
J Cell Physiol; 2006 Jan; 206(1):138-46. PubMed ID: 15965903
[TBL] [Abstract][Full Text] [Related]
46. Molecular signaling cascade in DNA bisintercalator, echinomycin-induced apoptosis of HT-29 cells: evidence of the apoptotic process via activation of the cytochrome c-ERK-caspase-3 pathway.
Park JY; Ryang YS; Shim KY; Lee JI; Kim HS; Kim YH; Kim SK
Int J Biochem Cell Biol; 2006 Feb; 38(2):244-54. PubMed ID: 16214385
[TBL] [Abstract][Full Text] [Related]
47. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
48. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
Varfolomeev E; Vucic D
Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
[TBL] [Abstract][Full Text] [Related]
49. Inhibitor of apoptosis proteins and apoptosis.
Wei Y; Fan T; Yu M
Acta Biochim Biophys Sin (Shanghai); 2008 Apr; 40(4):278-88. PubMed ID: 18401525
[TBL] [Abstract][Full Text] [Related]
50. [Participation of viral and cellular IAP proteins in regulation of apoptosis and cell survival].
Grzelakowska-Sztabert B
Postepy Biochem; 1999; 45(3):167-76. PubMed ID: 10761191
[No Abstract] [Full Text] [Related]
51. Apoptosis. The little devil of death.
De Laurenzi V; Melino G
Nature; 2000 Jul; 406(6792):135-6. PubMed ID: 10910336
[No Abstract] [Full Text] [Related]
52. IAPs: more than just inhibitors of apoptosis proteins.
Dubrez-Daloz L; Dupoux A; Cartier J
Cell Cycle; 2008 Apr; 7(8):1036-46. PubMed ID: 18414036
[TBL] [Abstract][Full Text] [Related]
53. IAPs as therapeutic targets in haematological malignancies.
Langemeijer SM; de Graaf AO; Jansen JH
Expert Opin Ther Targets; 2008 Aug; 12(8):981-93. PubMed ID: 18620520
[TBL] [Abstract][Full Text] [Related]
54. Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.
Miura K; Fujibuchi W; Ishida K; Naitoh T; Ogawa H; Ando T; Yazaki N; Watanabe K; Haneda S; Shibata C; Sasaki I
Surg Today; 2011 Feb; 41(2):175-82. PubMed ID: 21264751
[TBL] [Abstract][Full Text] [Related]
55. [The role of caspases in the apoptosis process].
Smolewski P
Postepy Hig Med Dosw; 2003; 57(3):335-54. PubMed ID: 14524250
[TBL] [Abstract][Full Text] [Related]
56. Targeting inhibitor of apoptosis proteins (IAPs) for diagnosis and treatment of human diseases.
Fulda S; Debatin KM
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):81-9. PubMed ID: 18221028
[TBL] [Abstract][Full Text] [Related]
57. An Apollon vista of death and destruction.
Martin SJ
Nat Cell Biol; 2004 Sep; 6(9):804-6. PubMed ID: 15340445
[No Abstract] [Full Text] [Related]
58. Inhibitor of apoptosis proteins in human health and disease.
Hrdinka M; Yabal M
Genes Immun; 2019 Nov; 20(8):641-650. PubMed ID: 31110240
[TBL] [Abstract][Full Text] [Related]
59. IAPs: the last choice to survive.
Brancolini C
Adv Clin Path; 2002 Apr; 6(2):67-75. PubMed ID: 19753728
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Liang J; Zhao W; Tong P; Li P; Zhao Y; Li H; Liang J
BMC Med Genomics; 2020 Jan; 13(1):7. PubMed ID: 31964418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
